Trial record 5 of 144 for:    resveratrol

Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial (RESULT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03253913
Recruitment Status : Recruiting
First Posted : August 18, 2017
Last Update Posted : March 20, 2018
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Nishant Gupta, University of Cincinnati

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 30, 2020
  Estimated Study Completion Date : June 30, 2020